Iovera Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $140M

Iovera General Information

Description

Developer of a cryoneurolysis-based pain management system designed to provide targeted, drug-free pain relief. The company's system uses controlled freezing to temporarily block peripheral nerve signals for up to 90 days, enabling healthcare providers to manage osteoarthritis and post-surgical pain, support patient recovery, and reduce opioid use following knee replacement surgery.

Contact Information

Website
www.iovera.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 2000 Sierra Point Parkway
  • Suite 900
  • Brisbane, CA 94005
  • United States
Primary Industry
Therapeutic Devices
Parent Company
Zimmer Biomet Holdings
Vertical(s)
Corporate Office
  • 2000 Sierra Point Parkway
  • Suite 900
  • Brisbane, CA 94005
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Iovera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Merger/Acquisition 31-Jul-2026 $140M Completed Profitable
10. Merger/Acquisition 09-Apr-2019 Completed Profitable
9. Later Stage VC 13-Nov-2018 Completed Profitable
8. Later Stage VC (Series G) 08-Mar-2018 Completed Profitable
7. Later Stage VC (Series F) 18-Oct-2017 Completed Profitable
6. Later Stage VC (Series E2) 09-Dec-2014 Completed Profitable
5. Later Stage VC (Series E1) 12-Sep-2013 Completed Profitable
4. Later Stage VC (Series D) 21-Mar-2012 Completed Profitable
3. Later Stage VC (Series C) 16-Mar-2011 $18.8M $33.5M Completed Profitable
2. Early Stage VC (Series B) 13-Oct-2008 $11.4M $14.8M Completed Profitable
To view Iovera’s complete valuation and funding history, request access »

Iovera Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series G
Series F
Series E2 25,000,000 $0.000100 $0.87 $0.87 1x $0.87 7.78%
Junior Preferred 3,000,000 $0.000100
To view Iovera’s complete cap table history, request access »

Iovera Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a cryoneurolysis-based pain management system designed to provide targeted, drug-free pain relief. The comp
Therapeutic Devices
Brisbane, CA

Westport, CT
 

Santa Clarita, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Iovera Competitors (12)

One of Iovera’s 12 competitors is BioWave, a Venture Capital-Backed company based in Westport, CT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioWave Venture Capital-Backed Westport, CT
Valencia Technologies Formerly VC-backed Santa Clarita, CA
Nevro Formerly VC-backed Redwood City, CA
Spine Wave Venture Capital-Backed Shelton, CT
Abiomed Corporate Backed or Acquired Danvers, MA
You’re viewing 5 of 12 competitors. Get the full list »

Iovera Patents

Iovera Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-241632-S Cover for cryogenic needle tip Active 08-Jan-2025
CA-241708-S Cover for cryogenic needle tip Active 08-Jan-2025
CA-249942-S Cover for cryogenic needle tip Active 08-Jan-2025
CA-251953-S Cover for cryogenic needle tip Active 08-Jan-2025
CA-251955-S Cover for cryogenic needle tip Active 08-Jan-2025
To view Iovera’s complete patent history, request access »

Iovera Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Accuitive Medical Ventures Venture Capital Minority
American Equities Overseas Lender/Debt Provider Minority
De Novo Ventures Venture Capital Minority
Medicis Capital Venture Capital Minority
NMT Capital PE/Buyout Minority
You’re viewing 5 of 10 investors. Get the full list »

Iovera FAQs

  • When was Iovera founded?

    Iovera was founded in 2005.

  • Where is Iovera headquartered?

    Iovera is headquartered in Brisbane, CA.

  • What industry is Iovera in?

    Iovera’s primary industry is Therapeutic Devices.

  • Is Iovera a private or public company?

    Iovera is a Private company.

  • What is the current valuation of Iovera?

    The current valuation of Iovera is .

  • What is Iovera’s current revenue?

    The current revenue for Iovera is .

  • How much funding has Iovera raised over time?

    Iovera has raised $183M.

  • Who are Iovera’s investors?

    Accuitive Medical Ventures, American Equities Overseas, De Novo Ventures, Medicis Capital, and NMT Capital are 5 of 10 investors who have invested in Iovera.

  • Who are Iovera’s competitors?

    BioWave, Valencia Technologies, Nevro, Spine Wave, and Abiomed are some of the 12 competitors of Iovera.

  • When was Iovera acquired?

    Iovera was acquired on 31-Jul-2026.

  • Who acquired Iovera?

    Iovera was acquired by Zimmer Biomet Holdings.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process